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Iron(II)- and α-ketoglutarate-dependent (Fe/αKG) enzymes catalyze a large array of biologically 
important and chemically challenging reactions. Although the mechanism of hydroxylation 
reaction catalyzed by these enzymes has been revealed in great details, the mechanisms of other 
reactions are still largely unknown. Particularly, the molecular bases for controlling the diverse 
reaction outcomes branching from a common reactive intermediate, the ferryl (FeIV=O) 
intermediate, are not well understood. By using a combined biochemical, bio-organic, and 
spectroscopic approach, we have studied the mechanisms of two newly discovered Fe/αKG 
enzymes, FtmOx1 and AsqJ. The formal one catalyzes a novel endoperoxidation reaction, the 
latter one catalyzes a consecutive desaturation and epoxidation reaction. Our studies disclose 
some of the strategies utilized by Fe/αKG enzymes to control reactivity, namely the effect of 
redox/polar residues near the iron center, the electronic properties of the substrate, and the 




Iron(II)- and α-ketoglutarate (αKG, also known as 2-oxoglutarate)-dependent (Fe/αKG) 
enzymes constitute a large superfamily of non-heme iron-containing enzymes [1] discovered in 
microbes, plants, and animals. By using αKG as the co-substrate and molecular oxygen (O2) as 
the terminal oxidant, Fe/αKG enzymes catalyze a bewildering array of regio-/stereo-specific 
oxidative transformations, including hydroxylation, halogenation, endoperoxidation, 
desaturation, epoxidation, ring formation and ring expansion [2–6]. Some of them are key 
chemical steps in important biological pathways, such as DNA/RNA repair [7–11], gene 
regulation [12–23], O2 sensing [24–27], and natural product biosynthesis [28,29]. In recent years, some 
members of this family have also been considered as therapeutic targets for a wide range of 
diseases including cancer and anemia [30].  
 
Scheme 1. The Overall Reaction of Fe/αKG Enzyme Catalyzed Hydroxylation. R-H stands for the C-H 
bond being activated during the reaction. 
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Biochemical studies on Fe/αKG enzymes can be dated back more than half century ago. 
Early studies focused on characterizations of Prolyl 4R-Hydroxylase (P4H), Prolyl 3S-
Hydroxylase (P3H), and Lysyl 5R-Hydroxylase (PLOD) that catalyze the stereospecific 
conversion of proline or lysine to hydroxyl- proline or lysine [31–34]. These enzymes are involved 
in post-translational processing of collagen in mammals [35]. The requirement of Fe(II), αKG, 
and O2 for the enzyme activity, the regio- and stereo-specific hydroxylation site with the 
replacement of hydrogen atom on that site, the source of hydroxyl oxygen, as well as the 
production of equimolar quantities of hydroxylated product, succinate and CO2 were established 
by various biochemical activity assays with isotope labeled chemicals ([4-3H]proline, [1-14C] 
αKG, and 18O2). These studies have defined the overall reaction of Fe/αKG enzyme catalyzed 
hydroxylation reaction (Scheme 1). These early studies also identified ascorbic acid as an 
important reagent to enhance the enzyme activity, however, it was not directly involved in 
enzyme catalysis, but was viewed as a reducing reagent to reactivate the enzyme in multiple 
turn-over reactions, and likely to prevent iron from oxidizing to the ferric form [35]. Over the 
years, the Fe(II)-, αKG-, and O2-dependent hydroxylase reactivity has been further explored in 
other Fe/αKG enzymes discovered in many different biological pathways. Some examples are 
listed below. In fatty acid metabolism, two Fe/αKG dependent hydroxylases, 6-N-trimethyllysine 
and γ-butyrobetaine hydroxylases, have been identified in L-carnitine biosynthesis [36–39]. In free 
amino acid modification, many Fe/αKG dependent hydroxylases have been identified to produce 
hydroxylated amino acids with high regio-specificity, some of these products are further 
incorporated into antibiotics [40]. In pyrimidine metabolism, thymine 7-hydroxylase (T7H), one 
of the first characterized Fe/αKG dependent enzymes, catalyzes three sequential hydroxylation 
reactions to the methyl group of thymine, converting it to 5-carboxyuracil [41–44]. In sulfonate 
and sulfate metabolism, taurine dioxygenase (TauD) catalyses hydroxylation of taurine, which 
spontaneously decomposes to aminoacetaldehyde and sulfite [45,46]. In hypoxia signaling 
pathway, prolyl 4R-hydroxylases (P4Hs) are responsible for the modifications of the α-subunit of 
the hypoxia-inducible factor (HIF-1) in human, HIF-1 is the key component in the hyoxia 
signaling pathway [24,25]. Another commonly observed reaction catalyzed by Fe/αKG enzymes is 
demethylation, which can be viewed as hydroxylation on the methyl group of the substrate 
followed by the spontaneous loss of formaldehyde of the hydroxylated methyl group. Fe/αKG 
dependent demethylases have been found in gene regulation pathway, such as histone 
demethylation catalyzed by Fe/αKG enzyme JmjC [12–15,47], and in repairing DNA/RNA, such as 
demethylation of alkylated DNA/RNA by AlkB enzyme family [7,8,11,48]. Recently, more 
evidence suggests that Fe/αKG dependent demethylation on DNA/RNA may contribute to the 
epigenetic regulation by controlling the methylation status of DNA/RNA [20]. All these 
discoveries confirm the ubiquity and importance of Fe/αKG and O2-dependent hydroxylase 
reactivity in many fundamental biological processes. 
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Scheme 2. Diverse Catalytic Activities Exhibited by Fe/αKG Dependent Enzymes. 
Although hydroxylation is the most common reactivity exhibited by Fe/αKG enzyme family, 
other reactivities have also been discovered (Scheme 2). Three well-characterized members of 
the Fe/αKG enzyme family that exhibit interesting non-hydroxylation reactivity are 
deacetoxycephalosporin C synthase/deacetylcephalosporin C synthase (DAOCS/DACS), 
clavaminate synthase (CAS) [49–52], and carbapenem synthase (CarC) [53,54], they are all 
multifunctional enzymes involved in β-lactam antibiotic biosynthesis. DAOCS/DACS catalyzes 
a consecutive reaction including an unprecedented oxidative ring expansion of the penam ring of 
penicillin N (penN) to the cephem moiety of deacetoxycephalosporin C (DAOC), and further 
hydroxylation on the terminal methyl group on C3 of DAOC to form deacetylcephalosporin C 
(DAC). Interestingly, in bacteria, such as S. clavuligerus, the conversions from penN to DAOC, 
and DAOC to DAC are catalyzed by two separate but highly similar Fe/αKG enzymes, while in 
fungi, such as C. acremonium, a single enzyme catalyzes all the reactions. CAS is a remarkable 
trifunctional enzyme in the pathway of clavulanic acid biosynthesis found in S. clavuligerus, 
which catalyzes hydroxylation reaction followed by cyclization and desaturation reactions. 
Finally, CarC found in P. carotovorum catalyzes two sequential non-hydroxylation reactions: a 
unique redox neutral epimerization to convert (3S,5S)-carbapenam-3-carboxylate to (3S,5R)-
carbapenam-3-carboxylate, and further desaturation to yield (5R)-carbapenem-3-carboxylate. 
More non-hydroxylation reactivities have been identified in Fe/αKG enzymes in recent years, 
such as epoxidation catalyzed by hyoscyamine 6β-hydroxylase (H6H) in the biosynthesis of 
scopolamine [55–57], a alkaloid produced by H. niger; halogenation catalyzed by SyrB2 [58,59] in 
syringomycin E biosynthesis, a phytotoxin generated by P. syringae, and CytC3 [60,61]  in 
cytotrienin biosynthesis from Streptomyces sp.; endoperoxidation catalyzed by FtmOx1 in 
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C(sp2)-C(sp3) bond formation catalyzed by 2-ODD in the biosynthesis of podophyllotoxin [64], a 
natural product precursor of the chemotherapeutic etoposide in P. hexandrum. Thus all these 
studies not only establish the catalytic diversity of Fe/αKG enzymes, also raise a fundamental 
mechanistic question on how these diverse reactivities are controlled by this family of enzymes. 
Early mechanistic understandings of Fe/αKG enzyme catalyzed hydroxylation reaction were 
largely obtained from steady state kinetic studies on P4Hs. Based on these studies, Hanauske-
Abel and Günzler in 1982 put forward a general mechanism of the hydroxylation reaction 
catalyzed by Fe/αKG enzymes, where a ferryl intermediate as the key reactive species was 
proposed for the first time [65]. The experimental validation of this intermediate came more than 
20 years later from the seminal work from Bollinger, Krebs, and coworkers by using transient 
enzyme kinetics and spectroscopic tools [66,67]. At the same time, molecular level understandings 
of Fe/αKG enzymes were greatly enhanced from the high-resolution crystal structures of several 
Fe/αKG enzymes appeared in late 1990s and early 2000s [68–72]. These structures revealed a 
common protein fold, a double-stranded β-helix (DSBH), cupin, or jelly-roll, for Fe/αKG 
enzymes and related non-heme iron enzymes, and a highly conserved iron binding site consisting 
of a His-X-Asp/Glu…His (HXD/E…H) moiety, termed 2-His-1-carboxylate facial triad [73]. It 
was further suggested that thre  water molecules occupy three iron-binding sites in the resting 
state of enzyme to give an octahedral geometry of the iron center. For all the structural and 
spectroscopic characterized Fe/αKG enzymes, αKG forms a bidentate binding to the iron center 
by replacing two of the three water molecules, and the primary substrate binds in the vicinity of 
the iron center (an exception is αKG ethylene-forming enzyme (EFE), where in one of the 
reported crystal structures, a mono-dentate binding of αKG is proposed [74]). Model chemistry 
studies on mimicking the structures of the ferrous and the ferryl state of enzymes also greatly 
enhanced our understandings on Fe/αKG enzymes [5,75]. Furthermore, all these experimental 
efforts were joined by computational studies, in particular density functional theory (DFT) 
calculations [76–79] and more recently large-scale quantum mechanics/molecular mechanics 
(QM/MM) calculations [80–83], to elucidate the fundamental structural/function relationship of 
Fe/αKG enzymes. 
In this review, we will first briefly summarize the current mechanistic understandings of 
Fe/αKG enzymes and the major questions remain to be solved in understanding the catalytic 
diversity of this enzyme family. Secondly, we will describe our recent results on the mechanistic 
elucidation of two newly discovered Fe/αKG enzymes, FtmOx1 and AsqJ, by using a 
multifaceted approach, including organic synthesis, structural determination, transient kinetics, 
and advanced spectroscopic methods, the implications of these results in improving our 
understanding of Fe/αKG enzymes will also be discussed. 
 
2. Iron Center Structure and General Mechanism of Fe/αKG Enzymes: 
 
The resting state Fe/αKG enzymes contains a mononuclear ferrous (Fe(II)) center, which is 
ligated by a conserved 2-His-1-carboxylate facial triad, thus creating three open coordination 
sites for the Fe(II) center (Figure 1). This structurally conserved active center was first revealed 
in the crystal structure of isopenicillin N synthase (IPNS), a mononuclear nonheme iron enzyme 
related to Fe/αKG enzymes, yet not requiring αKG as the co-substrate [68,84,85]. Later on, 
crystallographic studies revealed similar active center structural motifs in Fe/αKG enzymes, such 
as in DAOCS [69] and TauD [71]. Exceptions to this conserved 2-His-1-carboxylate facial triad 
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are those found in αKG dependent halogenases where the iron-ligated carboxylate group is 
replaced with halides [86–88]. These crystal structures further illustrated that in the absence of 
αKG and the primary substrate of the enzymes, the open coordination sites of the Fe(II) center 
are generally occupied by water molecules (Figure 1). The crystallographic results were 
confirmed by spectroscopic studies. By using circular dichroism (CD) and magnetic circular 
dichroism (MCD) [89], Solomon and coworkers studied the Fe(II) center in CAS [51,52] and TauD 
[90]. Two d-d transitions in the near IR region with positive MCD bands were observed with an 
energy splitting of Δ5Eg ~ 2000 cm-1, which is indicative of a distorted six-coordinated high-spin 
(S = 2) Fe(II) center (Figure 1).  
As the co-substrate, αKG directly binds to the Fe(II) center in a bi-dentate fashion through 
C2-carbonyl oxygen and one of its C1 carboxylate oxygens, resulting in the replacement of two 
coordinated water molecules (Figure 1). This binding mode was first revealed through MCD 
studies on CAS [51], and then confirmed by the crystallographic data on other Fe/αKG enzymes. 
This Fe(II)-αKG binary complex retains a six-coordinated geometry with one water molecule 
still coordinates with the Fe(II). Another spectroscopic feature of this binary complex is a weak 
metal-to-ligand charge transfer (MLCT) band observed at ~ 520 nm with the extinction 
coefficient of ~ 200 M-1 cm-1, which gives a pink/purple color to the Fe(II)-αKG binary complex 
in Fe/αKG enzymes (Figure 1) [51,91]. This MLCT band has been assigned as the transitions 
between d orbitals of Fe (dyz, dz2 and dx2-y2) and the π* of the α-keto carboxylate moiety of αKG 
[51]. Hausinger and co-workers [91], as well as other research groups, has utilized this MLCT 
band to determine the binding affinities of Fe(II), αKG, and the primary substrate in Fe/αKG 
enzymes. Although the αKG binding mode to the Fe(II) center is almost exclusively bi-dentate 
with the C2-carbonyl oxygen invariantly trans to carboxylate of the 2-His-1-carboxylate facial 
triad, the position of the αKG C1 carboxylate adopts two orientations revealed by the reported 
crystallographic data of various Fe/αKG enzymes [92]. In one orientation, the C1 carboxylate 
group is located trans to the proximal (closer to N-terminus of the protein) histidine of the 2-His-
1-carboxylate facial triad (the in-line configuration). In the other orientation, the C1 carboxylate 
group is located trans to the distal histidine (the off-line configuration) (Figure 1). The 
mechanistic implication of these two distinct configurations is still not fully understood. 
Furthermore, a mono-dentate binding of αKG to the Fe(II) center was recently observed in one 
of the reported  crystal structures of the Fe(II)-αKG binary complex of EFE enzyme [74], which 
leads to the dramatically decreased MLCT optical band in the EFE Fe(II)-αKG binary complex 
[93,94]. This is the only known exception to the otherwise conserved bi-dentate αKG-binding 
mode to the Fe(II) center of Fe/αKG enzymes. 
The formation of the reaction complex in Fe/αKG enzymes is completed by the binding of 
the primary substrate, which is located in the vicinity of the Fe(II) center and stabilized through 
various hydrophobic or hydrophilic interactions provided by the surrounding protein residues. 
MCD studies [52,90] on CAS, TauD, and αKG dependent halogenases revealed that the binding of 
the primary substrate facilitates the conversion of the six-coordinated Fe(II) center to a five-
coordinated one through the elimination of the water molecule (or the weakening the water 
binding) in the Fe(II)-αKG binary complex (Figure 1). Mössbauer analyses on the Fe(II) state of 
TauD were also consistent with the MCD results [66,67]. In going from the TauD-Fe(II) binary 
complex to the TauD-Fe(II)-αKG-Taurine quaternary complex, isomer shift (from 1.27 mm/s to 
1.16 mm/s) and quadrupole splitting (from 3.06 mm/s to 2.76 mm/s) decrease were observed, 
indicating a conversion from a 6-coordinated Fe(II) center to a five-coordinated center. The 
primary substrate binding also causes a subtle blue shift with an increase of the extinction 
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coefficient on the MLCT band at ~ 520 nm. Using this behavior, Hausinger and coworkers 
determined the binding affinity of taurine, the primary substrate, to TauD [91]. This iron center 
structural change is further proposed to promote rapid O2 addition at the onset of Fe/αKG 
enzyme catalysis where it is supported by transient kinetic studies. For example, in the case of 
TauD, the binding of taurine activates the Fe(II) center for reaction with O2 by 1000-fold [67,95]. 
This substrate triggered O2 addition is thought to serve as a protection mechanism to prevent 
unwanted O2 activation in order to avoid enzyme self-oxidation.  
 
Figure 1. Iron Center Structures and the Related Spectroscopic Features. Panel A: Iron center structures 
with and without αKG (or enzyme inhibitor, NOG) and primary substrate binding as well as In-line and 
Off-line binding mode of αKG. Panel B: Selected spectroscopic features of Fe(II) only, Fe(II)-αKG 
complex, and Fe(II)-αKG-substrate complex. Panel C: Selected spectroscopic features of the ferryl 
intermediate. 
The general mechanism of the hydroxylation reaction (Scheme 3) catalyzed by Fe/αKG 
enzymes proposed initially by Hanauske-Abel and Günzler in 1982 predicts that the addition of 
O2 to the reaction complex (Enzyme-Fe(II)-αKG-substrate, or the tertiary complex) leads to 
formation of an Fe(III)-superoxo intermediate, followed by an Fe(IV)-peroxo bicyclic 
intermediate  [65]. The decay of the latter intermediate through the simultaneous O-O bond 
cleavage and the conversion of αKG to succinate by decarboxylation affords formation of an 
unprecedented ferryl (FeIV=O) intermediate. The existence of this intermediate was validated by 
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[66]. Since then, this intermediate has been observed in a dozen of Fe/αKG and related enzymes, 
confirming that it is the conserved reactive intermediate in the Fe/αKG enzyme catalysis. Due to 
the highly reactive nature of the ferryl intermediate, its detection relies on the application of 
spectroscopic tools coupled with freeze quench technique. The frequently used spectroscopic 
technique is Mössbauer spectroscopy. All the reported ferryl intermediates have similar isomer 
shift (δ = 0.22 – 0.32 mm/s) and quadrupole splitting (ΔEQ = 0.7 – 1.1 mm/s) [54,59,61,66,96–100] 
(Figure 1). These Mössbauer parameters confirmed the oxidation state of the ferryl intermediate 
to be Fe4+. The high-field Mössbauer studies also revealed that the ferryl intermediate has a high-
spin (S = 2) ground electronic state. Extended X-ray absorption fine structure (EXAFS) 
spectroscopy revealed a short Fe-oxo bond (~1.60-1.65 Å) in the ferryl species [59,100,101] (Figure 
1) which was confirmed by resonance Raman study showing that the Fe-oxo stretching 
frequency at ~825 cm-1 [102,103] (Figure 1). However, the detailed structure of the ferryl 
intermediate is still n t available. By using nuclear resonance vibrational spectroscopy (NRVS), 
Solomon and coworkers studied vibrational features of the ferryl intermediate of SyrB2, an αKG 
dependent halogenase, and suggested that the SyrB2 ferryl intermediate is most likely five-
coordinated [104]. However, a detailed study combining spectroscopic data with density 
functional calculations (DFT) suggested that both six- and five-coordinated geometries are 
possible for the TauD ferryl intermediate [105]. 
 
Scheme 3. Generally Accepted Mechanism of Fe/αKG Enzyme Catalyzed Hydroxylation Reaction. 
The decay of the ferryl intermediate, in most cases (Fe/αKG enzyme catalyzed epoxidation is 
an exception, see section 4), goes through a C-H activation pathway where the Fe(IV)=O moiety 
abstracts a hydrogen atom (hydrogen atom transfer, HAT) from the targeted C-H bond of the 
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direct evidence showing that the ferryl intermediate is responsible for the C-H activation came 
from the demonstration of hydrogen/deuterium kinetic isotope effect (H/D KIE) on the decay 
kinetics of the ferryl intermediate in TauD [106]. A H/D KIE of ~ 50 was observed when the 
designated hydrogen atom was replaced by a deuterium, such as C1-2H2-taurine. Until now, the 
H/D KIEs up to 80 have been observed in various Fe/αKG enzymes [107]. Such a high H/D KIE 
value suggests that the C-H activation step by the ferryl intermediate consists of a significant 
hydrogen atom tunneling contribution. To gauge Fe(IV)-oxo reactivity toward C-H bond with 
different bond strength,   By utilizing substrate analogs with different C-H bond strength, ranging 
from 94 to 106 kcal/mol, Bollinger, Krebs and coworkers further systematically studied the 
ferryl reactivity in SyrB2, and revealed that the ferryl intermediate in SyrB2 is capable of 
activating C-H bond with bond dissociation energy up to 100 kcal/mol [59].  
So far, there is very limited information regarding the detailed electronic and geometric 
structures of the ferric-hydroxo intermediate after the decay of the ferryl intermediate, and the 
resulted substrate radical. For all the characterized αKG-dependent hydroxylases and 
halogenases, such an intermediate is simply unattainable due to its fleeting nature. For non-
hydroxylation reaction, there are two examples that this type of intermediate does accumulate. 
One is from CarC catalyzed stereoinversion [54], the other is from FtmOx1 catalyzed 
endoperoxdation (See section 3 for details). It is generally accepted that the completion of 
hydroxylation reaction is accomplished by the formation of a C-O bond between the hydroxyl 
group from the ferric-hydroxo intermediate and the substrate radical through the “OH-rebound” 
pathway that was first proposed in cytochrome P-450 dependent iron enzymes [108]. 
Alternatively, in halogenation reaction, the iron bound halide group is rebounded to the substrate 
radical instead of the OH group. Finally, the release of the enzyme product and the regeneration 
of the enzyme quaternary complex have been studied in detail in TauD where the overall rate-
limiting step of Fe/αKG enzyme catalysis is the likely product release which is followed by a 
rapid and ordered binding of αKG and then the primary enzyme substrate to regenerate enzyme-
Fe(II)-αKG-substrate complex [46,91].  
Although, the general reaction mechanism, in particular for hydroxylation reaction, along 
with the iron center structures in the ferrous state of several Fe/αKG enzymes have been studied 
in great details, there are still major questions remain to be solved to improve fundamental 
understandings on Fe/αKG enzymes, which include (1) what are the molecular bases that are 
used to precise control the diverse reactivity outcomes, and (2) what are detailed mechanisms of 
Fe/αKG enzymes that catalyze novel but non-hydroxylation reactions. By using a multifaceted 
approach, including mechanistic probe design, structural determination, transient kinetics, and 
advanced spectroscopic methods, we have studied two newly discovered Fe/αKG enzymes, 
FtmOx1 and AsqJ. These studies enriched our understandings of Fe/αKG catalysis, and provided 
insights to start unraveling the strategies that Fe/αKG enzymes utilize to precise control the 
reaction outcomes. 
 
3. Elucidation of Endoperoxide Bond Formation by FtmOx1 
 
Endoperoxide containing natural products [109], isolated mainly from plants, fungi and 
marine organisms, exhibit a wide spectrum of pharmacological activities, including 
antimicrobial, antibacterial, and anticancer activities [110–112]. For example, Artemisinin, one of 
the notable endoperoxide containing natural products isolated from Artemisia annua, possesses 
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the most rapid action of all current drugs against the multidrug-resistant Plasmodium falciparum 
malaria (Scheme 4). Although the exact mode of action of Artemisinin to fight against malaria is 
still unknown, it is believed that the active part of the molecule, the unusual endoperoxide 
bridge, could form free radicals to attack various parasite proteins. Despite the beneficial effects 
to human health demonstrated by endoperoxide containing natural products, their biosynthesis, 
especially endoperoxide formation, is not well understood, which limits the availability of these 
compounds through chemical synthesis or biosynthesis in engineered organisms. The only well-
characterized endoperoxide biosynthetic enzyme is prostaglandin H synthase (COX), which is a 
heme-containing enzyme (Scheme 4) [113]. 
FtmOx1 is the first Fe/αKG dependent enzyme discovered to catalyze the endoperoxide bond 
formation reaction in the biosynthesis of tremorgenic mycotoxin in Aspergillus and Penicillium 
fungus strains. The initial biochemical study on FtmOx1 revealed that this enzyme converts 
fumitremorgin B (1) to verruculogen (2) by installing an endoperoxide between two prenyl 
moieties of fumitremorgin B in an αKG-, O2- and Fe(II)-dependent fashion (Scheme 4) [62]. 
More interestingly, O2 is directly incorporated into verruculogen without O-O bond scission, thus 
distinguishing FtmOx1 from all currently known Fe/αKG dependent enzymes. 
 
Scheme 4. Endoperoxidation Reaction Catalyzed by FtmOx1. 
To gain molecular level details about this unique transformation, we used a combined 
biochemical and biophysical approach to unravel the reaction mechanism of FtmOx1 [63]. The 
Fe(II)-loaded heterogeneous expressed FtmOx1 binds αKG and develops a pink species observed 
at 520 nm, which is originated from the typical MLCT band of the Fe(II)-αKG binary complex in 
Fe/αKG dependent enzymes. The dissociation contant of αKG to the Fe(II) center was 
determined to be ~ 185 µM, which is similar with those in other Fe/αKG dependent enzymes, 
such as TauD [91]. Without the presence of the primary substrate, the FtmOx1-Fe(II)-αKG binary 
complex develops a blue chromophore centered at ~ 600 nm (ε600 ~ 380 M-1 cm-1) after a 
prolonged incubation with O2. Tandem mass spectrometry analysis of this species indicated the 
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self-hydroxylation reaction has been reported in several Fe/αKG dependent enzymes. Usually, 
the kinetics of this type of reaction is slow and its precise mechanism is unknown. It has been 
suggested in TauD that the self-hydroxylation may go through a tyrosyl radical intermediate. 
Nonetheless, the observation of DOPA formation strongly suggests that Tyr224 is close to the 
iron center of FtmOx1. 
 
Figure 2. Iron Center Structure of FtmOx1. The figure was generated by overlaying of the crystal 
structure of the FtmOx1-Fe(II)-αKG ternary complex (PDB: 4Y5S) with that of the FtmOx1-Fe(II)-
substrate complex (PDB: 4ZON). 
The FtmOx1-Fe(II)-αKG ternary complex was further subjected to crystallographic studies. 
A 1.95 Å resolution crystal structure revealed that FtmOx1 exhibits a double-stranded β-helix 
(DSBH) fold, which is common for Fe/αKG enzymes (Figure 2). The Fe(II) center is ligated 
with the conserved 2-His-1-carboxylate facial triad with αKG binding to the Fe(II) in a bi-
dentate fashion and an additional water molecule occupying the remaining coordination site. The 
orientation of αKG adopts the off-line configuration (see Section 2), which is different from 
many other Fe/αKG enzymes, such as TauD, where an in-line configuration is observed [71]. 
Indeed, Tyr224 is located in the vicinity of the Fe(II) center, its oxygen atom of the hydroxyl 
group forms a hydrogen bond interaction with the coordinated water molecule. Although, we 
failed to obtain a crystal structure of the FtmOx1-Fe(II)-αKG-substrate quaternary complex, we 
did obtain a crystal structure of the FtmOx1-Fe(II)-substrate complex. When comparing with the 
structure of the binary complex, the overall structure of the iron center was not changed, more 
importantly, the positioning of Tyr224 was not altered. Rings A and B of the substrate, 
fumitremorgin B, form π-π stacking with Tyr224. Overlaying the iron centers in these two 
crystal structure allows us to visualize the relative positioning of the Fe(II) center, Tyr224, and 
the substrate. The off-line binding mode of αKG creates a situation, where the oxo group of the 
ferryl intermediate (presumably occupying the water position in the FtmOx1-Fe(II)-αKG binary 
complex) formed after the initial O2 activation could be pointing away from the C-H bond of the 
subtrate that is activated during the catalysis (C21-H). Thus, the positioning of Tyr224 within 
short distances to both the Fe(II) center ( 3.2 Å) and the C21 of the substrate (3.7 Å) makes this 
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Scheme 5. Observed Product Distribution in the WT (black box), Y224F (green box), and Y224A (purple 
box) FtmOx1 Reactions. 
To test this idea, we carried out enzyme assays and performed product analysis. The overall 
stoichiometry of the reaction shows that the formation of one molecule of verruculogen requires 
one molecule of fumitremorgin B and αKG, and two molecules of O2. This reaction 
stoichiometry is distinct from all other characterized Fe/αKG enzymes, where one molecule of 
O2 is consumed in a single catalytic cycle. In addition, in our assay conditions, the over-oxidized 
product 3 rather than verruculogen (2) was the dominant product. 3 was not reported in the initial 
biochemical study. It is likely that due to the presence of ascorbic acid, a condition used in the 
initial biochemical study [62], the over-oxidation was suppressed. In our study, ascorbic acid was 
omitted, thus the over-oxidized product may be generated. But, the mechanism of 3 formation is 
still unknown. Nevertheless, FtmOx1 can carry out endoperoxidation without the addition of any 
reducing agents in the reaction mixture. The evidence of the direct involvement of Tyr224 in 
FtmOx1 catalysis came from a site directed mutagenesis study. Y224F and Y224A variants were 
shown to convert the activity of FtmOx1 from endoperoxidation to classical 
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Scheme 6. Proposed Reaction Mechanism of FtmOx1 Catalyzed Endoperoxidation. 
Based on these observations, we proposed a possible reaction mechanism (Scheme 6). In this 
mechanism, several radical intermediates are involved: tyrosyl radical, substrate radical, peroxyl 
radical and product radical. To provide experimental evidence to support this proposed 
mechanism, we performed stopped-flow optical absorption spectroscopy (SF-Abs) and freeze 
quench (FQ) coupled electron paramagnetic resonance spectroscopy (EPR). We observed a 
transient radical intermediate in the reaction of wild type FtmOx1 (Figure 3a). This 
intermediate, termed Int420, exhibits an optical absorption feature centered at ~ 420 nm, which 
reached a maximum at ~ 0.2 s and decayed within 3 s. This kinetics matched well with the 
kinetics of substrate consumption and the product formation determined by chemical quench 
experiments, indicating that Int420 is a kinetically competent intermediate in the FtmOx1 
catalysis. More details about this intermediate came from FQ-EPR experiments (Figure 3 b,c). 
Two EPR signals were observed at 0.01 s, which maximized at ∼ 0.2 s after the rapid mixing of 
O2-saturated buffer with the FtmOx1-Fe(II)-αKG-fumitremorgin-B complex. The first EPR 
signal with resonances at g = 4.54, 4.26, and 3.93 belongs to a high-spin Fe3+ species having 
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axial and rhombic zero-field splitting parameters of |D| < 0.5 cm-1 and E/D ≈ 0.26, respectively. 
The second EPR signal was in the g = 2 region and most likely belongs to a radical species. The 
formation and decay of this radical signal closely followed the kinetics of the 420 nm absorption 
feature observed in SF-Abs experiments, indicating that they are from the same intermediate, 
Int420. Spin quantification of the EPR signals at ~ 0.2 s revealed that the Fe3+ and radical species 
accumulated to ~0.35 and ~0.25 equivalents, respectively. The width of the radical EPR signal 
(~12 mT edge-to-edge width) was significantly broader than that of magnetically isolated 
organic or protein radical signals [114]. Such broadening could be due to magnetic dipolar 
interactions of the radical species with an adjacent spin center, most likely the Fe3+ center. 
Similar radical signal broadening was observed in CarC catalyzed stereo-inversion, where a 
tyrosyl radical exhibited magnetic broadening in its EPR signal due to magnetic dipolar 
interactions with the close-by Fe3+ center [54]. However, the difference is that Int420 in FtmOx1 is 
less likely to be the tyrosyl radical due to its optical absorption feature that is distinct from that of 
a tyrosyl radical species. Rather, the radical signal from Int420 could be originated from a 
substrate or product radical. 
 
Figure 3. Spectroscopic Evidence for a Transient Radical in the FtmOx1 Catalyzed Reaction. Left: SF-
Abs spectra showing the formation and decay of Int420. The inset shows the 420 nm kinetic trace; middle: 
the corresponding X-band EPR spectra of Int420; right: the high-spin ferric species formed along with 
Int420. 
Although, the precise nature of Int420 and details of some aspects of the catalytic mechanism 
of FtmOx1 still await to be elucidated, by combining protein site-directed mutagenesis, 
crystallography, transient kinetics and spectroscopic characterizations, our study does provide 
novel insights into endoperoxidation reaction catalyzed by an Fe/αKG enzyme. In particular, the 
illustration of the critical involvement of Tyr224 in facilitating the endoperoxidation reaction 
outcome while suppressing the “OH-rebound” pathway, and the capture of an on-pathway 
radical intermediate in the native reactivity in FtmOx1, which is only the second case observed 
in Fe/αKG with CarC being the first to detect an on-pathway radical species. One important 
aspect is the exact function of Tyr224 in FtmOx1 catalysis. The current hypothesis suggests that 
it may be oxidized by the ferryl intermediate to form a tyrosyl radical, which is the actual key 
oxidant to perform the initial C-H activation (Scheme 6). However, such a radical signal has not 
been observed. Thermodynamically, this step may be less likely to happen. The reduction 
potentials of tyrosine in the form of polypeptide and some structured protein have been 
determined to be in the range of 0.8 to 1 V at pH 7 in aqueous solution (reference to SHE) 
[115,116]. Although there is no experimental data available on the redox potential of the enzymatic 
ferryl intermediates in non-heme enzymes, the limited data on synthetic model complexes 
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suggests that the reduction potential of the ferryl species is in the range < 0.5 V (vs. SHE) in 
acidic aqueous solution [117,118]. However, the precise reduction potentials of both tyrosine and 
the ferryl intermediate in the protein scaffold of Fe/αKG enzymes are not known, which makes it 
difficult to rule out the current hypothesis. Another possible function of Tyr224 is to provide a 
good hydrogen bond interaction through the OH group to the Fe(III)-OH species, thus slow 
down the OH-rebound step in the FtmOx1 reaction and promote the O2 addition to the incipient 
substrate radical. This hypothesis seems to be supported by the results from Y224F variant, 
which is still able to active substrate C-H bond but produces mainly the dealkylated product 
through presumably the OH-rebound pathway. Nevertheless, the current results on FtmOx1 
strongly suggest that one of the strategies that Fe/αKG enzymes utilize to diversity their 
reactivity is to strategically place redox active and/or polar residues around the iron center in 
order to alter the decay pathway of the incipient substrate radical in Fe/αKG enzyme catalysis. 
 
4. The Consecutive Desaturation and Epoxidation Catalyzed by AsqJ 
 
Viridicatin-type alkaloids consist of a subfamily of naturally abundant quinolone alkaloids. 
They have been isolated from both terrestrial and marine fungi of the genera Aspergillus and 
Penicillium [119–123], and exhibit pharmaceutically valuable biological activities, including 
antiviral (including anti-HIV), antibacterial, and antitumor activities [124–131]. Recently, a gene 
cluster from Aspergillus nidulans responsible for the biosynthesis of the viridicatin has been 
discovered [132]. In this study, an Fe/αKG enzyme, AsqJ, has been identified as the key enzyme 
to convert 4’-methoxy-cyclopeptin to 4’-methoxy-cyclopenin through sequential desaturation 
and epoxidation. Subsequently, 4’-methoxy-cyclopenin undergoes an elimination/rearrangement 
to produce 4’-methoxy-viridicatin (Scheme 7). Thus, AsqJ represents a small sub-family of 
Fe/αKG enzymes, which exhibit multi-functionality but are not hydroxylase. In addition, 
although olefin and epoxide are important functional groups found in many bioactive natural 
products, the reaction mechanisms responsible for the installation of these functional groups 
catalyzed by Fe/αKG enzymes are not well understood, and the factors that diverge the reactivity 
from hydroxylation to desaturation and epoxidation has not been carefully elucidated. Using a 
similar approach described in the study of FtmOx1, and further supplemented with mechanistic 
probe design, we have obtained several key insights. 
 
Scheme 7. AsqJ Catalyzed Sequential Desaturation and Epoxidation Followed by 
Elimination/Rearrangement to Yield Viridicatin. 
4.1 The AsqJ Catalyzed Desaturation. 
In nature, enzymes that catalyze olefin installation with C-H activation steps typically utilize 
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a metallo- or organic cofactor, such as thiolate heme, di-iron, nonheme-Fe, or flavin, as the 
reactive center to trigger this chemically challenging transformation. Among them, the 
desaturation mechanism in cytochrome P-450 enzymes [133,134] and di-iron containing fatty acyl 
desaturases [135–137] has been suggested to go through a pathway involving two consecutive 
hydrogen atom transfers (2-HAT pathway) (Scheme 8a). In Fe/αKG dependent enzymes, similar 
mechanism has been put forward in the studies of clavaminate synthase (CAS) [6,52,138] and 
flavone synthase I (FNS I) [139]. Although, it can be envisioned that P450 enzymes and di-iron 
desaturases carry out 2-HAT by using two potent oxidizing intermediates (Compound I followed 
by Compound II in P450s, or a (µ-oxo)diiron(IV/IV) species followed by a (µ-oxo)diiron(III/IV) 
species in di-iron enzymes), it is not obvious how Fe/αKG enzymes can utilize an analogous 
approach. Specifically, after the initial C-H bond cleavage by a proposed FeIV=O species, the 
resulting Fe(III)-OH species may not be potent enough for the second HAT event. Yet, based on 
the mechanistic studies on lipoxygenase, it has been hypothesized that the resulting Fe(III)-OH 
species may be suitable for the 2nd-HAT [52,140]. But, no direct trapping and characterizations of 
reactive intermediates to support or disapprove 2-HAT mechanism has been reported. In addition 
to 2-HAT pathway, a carbocation pathway proposed in some P450 enzymes [141,142], and a 
chemically precedent hydroxylation/dehydration pathway also need to be considered (Scheme 
8a). 
 
Scheme 8. (A). Possible reaction pathways account for Fe/αKG catalyzed desaturation reaction. 
(B) Mechanistic probes and product used to study AsqJ catalyzed desaturation. 
To distinguish these pathways, we carried out detailed mechanistic studies on AsqJ catalyzed 
C=C bond formation by using cyclopeptin [(S)-7-H], and its C3-stereoisomer, (R)-7-H (Scheme 
8b) [143]. A long time incubation of (S)-7-H or (R)-7-H with Fe(II) loaded AsqJ in the presence 
of excess αKG and O2 led to the complete consumption of both substrates, suggesting that both 
stereoisomers are the substrate of AsqJ. Interestingly, the formation of cyclopenin (9-H), but not 




(S)-7-H (R)-7-H 8-H 9-H
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formation of dehydrocyclopeptin as the initial product, chemical quench (CQ) experiments were 
carried out on both (S)-7-H or (R)-7-H. CQ coupled LC-MS analysis clearly demonstrated that 
for both stereoisomers, dehydrocyclopeptin (8-H) was formed as the major product within a short 
reaction time (< 2 s), and was further converted to 9-H in a longer reaction time frame (Figure 
4A). SF-Abs monitored AsqJ reactions also supported the results obtained from steady-state 
enzyme and CQ-LC-MS assays, showing that the decay kinetics of the MLCT feature of Fe(II)-
αKG complex were identical when (S)-7-H or (R)-7-H were used. This suggests that the two 
stereoisomers can trigger αKG consumption with similar efficacy (Figure 4B). In addition, a 
simultaneous increase of absorption at ~ 310 nm was also observed which was attributed to the 
formation of dehydrocyclopeptin (8-H). These results not only confirms the bi-functionality of 
AsqJ, but also indicates that the C3-chirality of the substrate does not perturb enzyme kinetics 
and product distribution in AsqJ catalyzed desaturation reaction. To provide structural support of 
this conclusion, we have recently obtained the crystal structures of (S)-7-H and (R)-7-H bound 
AsqJ with the resolution of 1.96 Å and 2.05 Å, respectively (Figure 4C). The overall protein 
structure as well as the active site geometry are similar to the published Ni bound AsqJ 
crystallographic structure (PDB: 5DAW) [144]. However, our results represent the first 
visualization of AsqJ in its native iron-bound form. It also worth of noticing that the binding 
configuration of αKG to the iron center in AsqJ is the offline mode, which is the same with that 
in FtmOx1. In the (S)-7-H bound AsqJ, the C3-H and one of C10-Hs are poised for HAT with 
iron-carbon distance of 4.5 and 4.8 Å, respectively. In contrast, in the case of (R)-7-H, only the 
C10-Hs point toward the iron center, the C3-H points away from it and poises at the opposite face 
due to the inversion of C3-stereochemistry.. Thus, the binding configuration of (R)-1-H implies 
that C10-H should be the first C-H activation site and the subsequent C-H activation at C3 
position should be abolished. In addition, FQ-Mössbauer experiments showed that no 
accumulation of the ferryl species was detected when (S)-7-H or (R)-7-H was used (Figure 4D), 
which may be attributed to the relatively weak bond strength of the benzylic C-H bond which 
results in short life-time of the ferry species. 
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Figure 4. (A) CQ-LC-MS traces showing the formation of 8-H and the production of 9-H at the expense 
of 8-H; (B) SF-Abs results on Fe(II)-αKG MLCT band decay (470nm) and desaturated product formation 
(310nm) kinetics, indicating highly similar enzyme kinetics when two C3-stereoisomers are used; (C) The 
crystal structures showing the binding configurations of (S)-7-H (green) and (R)-7-H (yellow) in the 
active site of AsqJ. Red asterisk indicates C3-H position; (D) FQ-Mössbauer spectra showing the 
formation of decay of the Fe(II)-succinate complex (green) with no observation of Fe(IV)-oxo species.  
The experimental results summarized in the previous section suggest that the first C-H bond 
being activated is one of the C10-Hs, and the 2-HAT pathway is unlikely utilized by AsqJ. 
However, to distinguish between the carbocation pathway and the hydroxylation/dehydration 
pathway, more experimentation is still needed. The tuning of electronic property of C10 position 
through the para-substitution effect on the phenyl moiety of the substrate may be an applicable 
strategy to differentiate these pathways. Since both 4’-methoxy-cyclopeptin and cyclopeptin can 
be taken as substrate by AsqJ and the para position is exposed to protein surface as illustrated by 
the crystal structures, the change of substituent at the para position should not create strong 
perturbation to the substrate binding. On the other hand, we also need to consider another 
scenario where the initial C-H activation happens at C3-H instead of C10-Hduring regular 
catalysis. The crystal structure revealed that both C3-H and one of C10-Hs of (S)-7-H have 
similar distances to the iron center (different by 0.3 Å), the C-H bond strengths on both carbons 
are also similar. Thus, the initial C-H activation may occur from C3-H when is (S)-7-H used. 
Nonetheless, different from FtmOx1 where the endoperoxidation reaction outcome is enforced 
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hydroxylation seems to rely on the decay pathway of the incipient substrate radical after the 
initial C-H activation step. More experimentation is needed to illustrate more details in this 
transformation. 
4.2 The AsqJ Catalyzed Epoxidation. 
In thiolate-heme containing enzymes, such as cytochrome P450s, choloroperoxidases (CPO), 
and their biomimetic model complexes [145,146], it is generally accepted that the key intermediate 
in olefin epoxidation is an Fe(IV)-oxo porphyrin-cation-radical species, Compound I, and the 
overall reaction is proceeded through electrophilic addition. Based on two-state reactivity of 
P450 Compound I, computational studies further suggest that the epoxidation could go through a 
step-wise or a concerted mechanism depending on which spin-state (doublet or quartet state) of 
Compound I is actually participated in the reaction. However, detailed mechanistic studies on 
non-heme iron enzyme catalyzed oxygen-addition reactions are much less developed than its 
counterpart, thiolate-heme containing enzymes. 
 
Figure 5. (A) SF-Abs results showing similar Fe(II)-αKG MLCT band decay kinetics by using 2-OMe 
and 2-H, indicating AsqJ has similar catalytic efficacy when reacting with these two substrates; (B) FQ-
Mössbauer results showing the accumulation and decay of FeIV=O (red traces) using 2-OMe; (C) LC-MS 
traces showing the effect of 18O2 and 16O2 to the product isotope distribution; (D) and (E) epoxidation 
mechanisms; (F) oxo-OH/OH2 tautomerism at FeIV=O. 
Using AsqJ as a model system, we explored the epoxidation mechanism catalyzed by 
Fe/αKG enzymes [147]. Dehydrocyclopeptin with two different para-substituents (8-OMe and 8-
H) were used as substrates. Both substrates exhibited similar triggering effect on αKG 
consumption determined by the decay kinetics of the Fe-αKG MLCT band (Figure 5A). For 
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intermediates at early time points (the top of accumulation was observed at 0.03 s). This is the 
first experimental demonstration that the ferryl intermediate is directly involved in epoxidation in 
the Fe/αKG enzymes. In addition, the para substitution on the phenyl moiety (-OMe vs. –H) 
clearly affects the life time of the Fe(IV)-oxo species, which was revealed by higher 
accumulation of such a species (~30% accumulation) when 8-H was used compared to 8-OMe 
(~20% accumulation, Figure 3b). By conducting experiments in 18O2/H216O environment, we 
showed that although epoxide oxygen was originated from O2, 18O/16O isotope scrambling was 
observed (Figure 5C). These results suggest the ferryl oxygen can exchange with the solvent. 
More importantly, the amount of O incorporation from solvent depended on the para substitution 
(~20% vs. ~80% of 16O incorporation with -OMe vs. –H, Figure 5C). This observation is in line 
with the modulation of the ferryl species life time by the para substitution. In short, these results 
strongly support the conclusion that the ferryl intermediate is the key reactive species during 
epoxidation, and a solvent exchangeable oxo-group exists in this reactive intermediate. 
Although, solvent exchangeable iron-oxo intermediate has been indicated in heme and non-heme 
containing enzymes [148–153] and biomimetic model complexes [154–158], our experimental results 
provided experimental evidence to confirm this oxo-exchange event. This exchange could be 
modeled by a fast oxo-hydroxo/water tautomerism of the ferryl species (Figure 5F). Two recent 
theoretical studies on AsqJ using QM/MM method also support this conclusion. 
It has been well documented in the literature that synthetic non-heme Fe(IV)-oxo species 
exhibit both HAT and OAT reactivities depending on the substrates used. Thus, it comes with no 
surprise that when AsqJ is challenged with the desaturated substrate, dehydrocyclopeptin, where 
no suitable C-H bond can be cleaved, the alternative epoxidation outcome occurs. Thus our study 
suggests that the intrinsic reactivity of the ferryl intermediate can also dictate the reaction 
outcomes in Fe/αKG enzyme catalysis. It is interesting to see when both C-H bond with 
moderate bond strength and olefin are presented to the ferryl intermediate, which reactivity is 
preferred. Such a comparative study would be difficult to carry out experimentally in enzymatic 
system, but could provide critical insights in the comparison of the intrinsic reactivities of the 
ferryl intermediates. 
4.3 AsqJ Catalysis Probed by Mössbauer Spectroscopy. 
Mössbauer spectroscopy has been used extensively in characterizing the iron center changes 
during the reaction catalyzed by Fe/αKG enzymes. In fact, the first direct experimental 
observation of a ferryl intermediate was provided by Mössbauer data. So far, a dozen of ferryl 
intermediates have been characterized by Mössbauer spectroscopy. In AsqJ, we have captured 
the ferryl intermediate in the epoxidation reaction, its Mössbauer parameters closely resemble 
those of other reported ferryl intermediates [147]. Furthermore, using Mössbauer, we have also 
observed four different ferrous species in AsqJ catalyzed reactions over the course of our studies 
[143,147]. A broad quadrupole doublet was observed for the AsqJ-Fe(II)-αKG ternary complex 
with isomer shift of 1.24 mm/s, quadrupole splittings of 2.24 mm/s, and linewidth of ~ 0.6 mm/s, 
which reflects a typical high-spin ferrous center. The broad linewidth suggests that the structure 
of this ternary complex is inhomogeneous, which could be resulted from structural flexibility of 
the iron center. With the introduction of substrates ((S)-7-H, (R)-7-H, 8-OMe, or 8-H), the AsqJ-
Fe(II)-αKG-substrate quaternary complex showed a quadrupole doublet with dramatically 
sharpened linewidth and altered Mössbauer parameters (Table 1). But the Mössbauer parameters 
are almost the same for different substrates used. The changes of Mössbauer parameters in going 
from the ternary complex to the quaternary complex suggest that the substrate binding, although 
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does not directly interact with the iron center, does perturb the iron center structure strong 
enough to a detectable level by Mössbauer. The sharpening of the Mössbauer absorption 
linewidth for the quaternary complex when compared with the ternary complex suggests that 
with substrate binding, the structure of the iron center becomes more homogeneous. This 
observation may be consistent with the previous MCD studies on CAS and TauD, revealing a 
structural transition from a 6-coordinated iron center to a 5-coordinated one by possibly the 
elimination of a water molecule, thus preparing the iron center for rapid addition of O2. 
 
Table 1. Mössbauer simulation parameters of the quaternary complex on various Fe/αKG 
enzymes. 





AsqJ•Fe(II)•αKG•(S)-7-H (or (R)-7-H) 1.25 2.54 0.40 143 
AsqJ•Fe(II)•αKG•8-OMe ( or 8-H) 1.24 2.52 0.36 147 
TauD•Fe(II)•αKG•taurine 1.16 2.76 - 66 











IsnB•Fe(II)•αKG•Trp-NC 1.24 3.09 -0.37 107 
a Only the magnitude of quadrupole splittings are listed; b The linewidth of the simulated quadrupole 
doublets, negative linewidth is defined as a convolution of 50% Lorentzian and 50% Gaussian lineshape. 
After the reaction of the AsqJ quaternary complex with O2, two different enzyme-product 
complexes were observed by Mössbauer (Table 2), both of them showed a quadrupole doublet 
typical of high-spin ferrous species, but with very different parameters from those of the initial 
quaternary complex. More interestingly, the enzyme-product complex observed in the 
desaturation reaction can be generated by incubating AsqJ-Fe(II) with succinate and 
dehydrocyclopeptin (compound 8) in anaerobic condition, thus confirming its identity. But the 
enzyme-product complex observed in the epoxidation reaction is transient, and cannot be 
reproduced by incubating AsqJ-Fe(II) with succinate and cyclopenin (9). The significant 
differences in the Mössbauer parameters of the two enzyme-product complex reflect the 
difference in iron center structures. Based on the current understanding, the desaturation reaction 
generates an iron bound water molecule derived from O2, but in the epoxidation reaction, such an 
iron-bound water molecule does not exist at the conclusion of the reaction. Apparantly, more 
detailed Mössbauer analysis on these ferrous species are needed to further elucidate the structual 
features of these Fe(II) centers. 
 
Table 2. Mössbauer simulation parameters of the enzyme-substrate complex on various Fe/αKG 
enzymes. 
Enzyme-Product Complex δ (mm/s)a |ΔEQ| (mm/s)a Γ 
(mm/s)b 
Ref  
AsqJ desaturation 1.28 1.83 -0.35 143 
AsqJ epoxidation 1.20 2.95 0.33 147 
TauD 1.17 2.56 - 67 
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IsnB 1.15 3.23 -0.30 107 
a Only the magnitude of quadrupole splittings are listed; b The linewidth of the simulated quadrupole 
doublets, negative linewidth is defined as a convolution of 50% Lorentzian and 50% Gaussian lineshape. 
 
5. Closing Remarks 
By using mononuclear iron center ligated with 2-His-1-carboxylate binding motif, Fe/αKG 
enzymes demonstrate truly remarkable capabilities in catalyzing diverse reactions. In addition to 
hydroxylation, other novel oxidative transformations have been discovered over the past 
decades. Along with cytochrome P450 enzyme family, these two enzyme families show great 
catalytic diversity. In some aspects, Fe/αKG enzymes may be better biocatalysts engineered by 
nature than cytochrome P450 enzymes, due to the presence of a flexible iron center structure 
(three iron coordination sites are available for co-substrate and O2 binding), the utilization of an 
abundant small molecule metabolite, αKG, and the independence of redox partners in catalysis. 
It is also intriguing to see that the diverse reactivities of Fe/αKG enzymes are exclusively 
initiated by the obligatory key intermediate in the catalytic cycle, the ferryl intermediate, with a 
single spin state accessible in the reaction. This is in strong contrast with cytochrome P450 
enzymes, where different reactive species (Compound 0, Compound I, and Compound II) and 
different spin states of the reactive intermediates (doublet- and quartet-spin states of Compound 
I) have been postulated to be involved in different catalytic events. Thus, Fe/αKG enzymes 
present an interesting mechanistic conundrum: how does nature utilizes an apparent simple 
active center structure via a conserved key reactive intermediate to produce a great complexity in 
reaction outcomes. The molecular basis for controlling the diverse reaction outcomes becomes 
the key to unlock this conundrum and to provide molecular level understandings of Fe/αKG 
enzyme catalysis. Our studies on FtmOx1 and AsqJ start unraveling some of the strategies 
utilized by Fe/αKG enzymes, such as the effect of redox/polar residues near the iron center, the 
electronic properties of the substrate, and the intrinsic reactivity of the ferryl intermediate (HAT 
vs. OAT). Our studies also illustrate the effectiveness of the combined biochemical and 
biophysical approach in elucidating Fe/αKG enzyme mechanisms. With aid of molecular 
dynamics simulations and quantum chemical calculations, this combined research approach 
provides a comprehensive understanding towards Fe/αKG enzyme catalysis. 
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